Search results
Top Studies From ESOC 2024 in Review
Medscape· 5 days agoMedscape NeurologyDiener on NeurologyCOMMENTARYTop Studies From European Stroke Organisation Congress 2024 in ReviewHans-Christoph Diener, MD, PhD...
Osteoarthritis Drugs Need Trials With Appropriate Endpoints
Medscape· 3 days agoFor the elusive target of disease-modifying OA drugs (DMOADs), "there have been a lot of...
Lifestyle Changes Still Net Benefits in OA, RA After 2 Years
Medscape· 6 days agoAt the European Alliance of Associations for Rheumatology (EULAR) 2024 Annual Meeting, Carlijn...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 4 days agoWith a safety profile comparable with that seen in adult patients, ixekizumab "met the prespecified...
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach...
Morningstar· 4 days agoPALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
Medscape· 3 days agoThis marks the first approval for a KRAS inhibitor to treat CRC.
Slowing inflammation may boost immunotherapy’s e | Newswise
Newswise· 6 days agoPHILADELPHIA – Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a ...
Why Don't Migraine Patients Seek Treatment?
Medscape· 5 days agoNearly one in three patients with migraine is reluctant to seek medical help and many blame health care providers, results of a recent survey showed....
A New Psychotherapeutic 'Gold Standard' for Chronic Pain?
Medscape· 5 days agoA single course of treatment with emotional awareness and expression therapy (EAET) was associated...
In It Together: Doctor and Patient on GLP-1s
Medscape· 4 days agoEarlier this year, Fernandez found a new clinician who suggested he take a glucagon-like peptide 1 (GLP-1) receptor agonist for weight loss. When...